Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 30.7M shares as of Nov 8, 2024 (10-Q).⊙
EVIDENCE — filed/published fact
SourceSEC XBRL, cover-page share count
Fielddei:EntityCommonStockSharesOutstanding
As of2024-11-08
HowThe newest cover-page count as filed, whatever its age. The float checker applies a 200-day freshness rule and sets this beside the balance-sheet count.
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 11, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Balance-sheet fair value of warrants: $4,000 as of Dec 31, 2022.
Convertible notes
No convertible-note facts tagged in the 10-Q filed Aug 11, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
Shares outstanding
30.7M
Nov 8, 2024
+ Series Common Stock Warrants (if exercised)
1,000
Jun 30, 2026
Fully diluted estimate
30.7M
+0.0% vs O/S
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
S-3Aug 15, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
S-1Jan 23, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →
Last 12 months: 2 executed · 0 registered.
EXECUTEDOct 1, 2026Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
UPDATESep 30, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →
EXECUTEDApr 28, 2026Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EXECUTEDAug 14, 2025Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EFFECTIVEAug 26, 2024SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDAug 15, 2024S-3 registration — capacity to sell shares, not a sale yetS-3 →
EXECUTEDJan 29, 2024Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
EFFECTIVEJan 25, 2024SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDJan 24, 2024S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
REGISTEREDJan 23, 2024S-1 registration — capacity to sell shares, not a sale yetS-1 →
EXECUTEDJul 17, 2023Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
REGISTEREDJul 13, 2023S-1MEF registration — capacity to sell shares, not a sale yetS-1MEF →
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.